C2i Genomics Acquires Sequencing Lab QNA Dx

NEW YORK — C2i Genomics said on Thursday that it has acquired CLIA-certified sequencing lab QNA Dx in an effort to speed the commercialization of its MRDetect cancer monitoring platform.

Financial terms of the transaction were not disclosed. C2i said that it will retain all of QNA’s employees and continue its lab operations.

Source link

Most Popular

To Top